Microrna Target Site Blocking Oligos And Uses Thereof

Patent No. EP2113567 (titled "Microrna Target Site Blocking Oligos And Uses Thereof") was filed by Exiqon on Dec 21, 2007. The application was issued on Apr 3, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
RANGER BIOTECHNOLOGIESJan 3, 2020BUDDE SCHOU

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2113567

EXIQON
Application Number
EP09165187A
Filing Date
Dec 21, 2007
Status
Opposition Rejected
Mar 18, 2022
Publication Date
Apr 3, 2019